Jeff Aronin and Paragon Biosciences: Creating Innovative Medicines for Complex Medicines

Jeff Aronin, the chief executive officer (CEO) of Paragon Biosciences, has ultimately been an innovative leader in the bioscience industry.

Before he was CEO of his current company, he founded Ovation Pharmaceuticals in 2000 and he worked there as the president and CEO from 2000 to 2009.  Ovation then merged with Lundbeck and Jeff Aronin became the CEO of Lundbeck for the transition period to ensure that the merger went smoothly.

After dealing with the merger, Jeff Aronin joined Paragon Biosciences as the chairman and CEO. Paragon is firm that invests in biopharmaceuticals and international healthcare development. He has also been chairman of companies under the Paragon umbrella like Harmony Biosciences, Castle Creek Pharmaceuticals, a biopharmaceutical prescription company that does research and development.

For the last 20 years, Aronin has used his knowledge to develop innovative healthcare companies and international biotech companies. His experience has allowed to encourage and develop innovations when it comes to rare diseases, complex science, and drug development (Thenewsversion).

When it comes to bringing a group of scientists and business people together to deal with drug treatments and therapies, Aronin has great enthusiasm. These groups, led by Jeff Aronin, are known for their success rate of bringing new medications to the public with one of the goals being to make the lives of certain patients better. In the past, his groups have been successful in getting 13 new drugs approved through the FDA. That rate of success is better than the vast majority of companies in the medical industry.

Despite having a busy schedule, Jeff Aronin does take time to become a mentor for numerous budding business people.

Jeff Aronin’s current company, Paragon, has a three-step process for research and development. The first step of the process is to identify the disease that patients need a medicine the most for. This disease also has few ways to get the treatment that they need for the disease. The second step is to invest and develop companies that will help them in creating the new medicine. The third step is to create the drug and to get approval from the FDA. This company has been highly successful in getting approval from the FDA.

Jeff Aronin and Paragon work together to make innovative medicines for the people.